Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1960 3
1964 2
1965 1
1966 2
1968 1
1969 4
1970 1
1971 3
1972 2
1977 1
1981 2
1982 2
1988 1
1994 1
1995 1
1996 1
1997 6
1998 1
1999 4
2000 1
2001 3
2002 2
2003 2
2004 1
2005 2
2006 2
2007 3
2008 5
2009 1
2010 2
2011 6
2012 7
2013 6
2014 11
2015 9
2016 8
2017 8
2018 11
2019 7
2020 14
2021 9
2022 9
2023 12
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

169 results

Results by year

Filters applied: . Clear all
Page 1
Implications of Five Different Risk Models In Primary Prevention Guidelines.
Sud M, Sivaswamy A, Austin PC, Abdel-Qadir H, Anderson TJ, Naimark DMJ, Lee DS, Roifman I, Thanassoulis G, Tu K, Wijeysundera HC, Ko DT. Sud M, et al. Among authors: naimark dmj. Eur Heart J Qual Care Clin Outcomes. 2024 May 11:qcae034. doi: 10.1093/ehjqcco/qcae034. Online ahead of print. Eur Heart J Qual Care Clin Outcomes. 2024. PMID: 38734893
Time to SGLT2 Inhibitors Initiation in Patients With Heart Failure.
Moon J, Udell JA, Chong A, Fang J, Austin PC, Ko DT, Stukel TA, Atzema CL, Booth GL, Tu K, Naimark DMJ, Jackevicius CA. Moon J, et al. Among authors: naimark dmj. J Am Heart Assoc. 2024 Apr 16;13(8):e032296. doi: 10.1161/JAHA.123.032296. Epub 2024 Apr 2. J Am Heart Assoc. 2024. PMID: 38563368 Free article. No abstract available.
Validation of the European SCORE2 models in a Canadian primary care cohort.
Sud M, Sivaswamy A, Austin PC, Abdel-Qadir H, Anderson TJ, Khera R, Naimark DMJ, Lee DS, Roifman I, Thanassoulis G, Tu K, Wijeysundera HC, Ko DT. Sud M, et al. Among authors: naimark dmj. Eur J Prev Cardiol. 2024 Apr 18;31(6):668-676. doi: 10.1093/eurjpc/zwad352. Eur J Prev Cardiol. 2024. PMID: 37946603
Cost-Effectiveness Analysis of CT-Based Finite Element Modeling for Osteoporosis Screening in Secondary Fracture Prevention: An Early Health Technology Assessment in the Netherlands.
Li J, Viceconti M, Li X, Bhattacharya P, Naimark DMJ, Osseyran A. Li J, et al. Among authors: naimark dmj. MDM Policy Pract. 2023 Oct 26;8(2):23814683231202993. doi: 10.1177/23814683231202993. eCollection 2023 Jul-Dec. MDM Policy Pract. 2023. PMID: 37900721 Free PMC article.
Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis.
Writing Group for the CKD Prognosis Consortium; Grams ME, Coresh J, Matsushita K, Ballew SH, Sang Y, Surapaneni A, Alencar de Pinho N, Anderson A, Appel LJ, Ärnlöv J, Azizi F, Bansal N, Bell S, Bilo HJG, Brunskill NJ, Carrero JJ, Chadban S, Chalmers J, Chen J, Ciemins E, Cirillo M, Ebert N, Evans M, Ferreiro A, Fu EL, Fukagawa M, Green JA, Gutierrez OM, Herrington WG, Hwang SJ, Inker LA, Iseki K, Jafar T, Jassal SK, Jha V, Kadota A, Katz R, Köttgen A, Konta T, Kronenberg F, Lee BJ, Lees J, Levin A, Looker HC, Major R, Melzer Cohen C, Mieno M, Miyazaki M, Moranne O, Muraki I, Naimark D, Nitsch D, Oh W, Pena M, Purnell TS, Sabanayagam C, Satoh M, Sawhney S, Schaeffner E, Schöttker B, Shen JI, Shlipak MG, Sinha S, Stengel B, Sumida K, Tonelli M, Valdivielso JM, van Zuilen AD, Visseren FLJ, Wang AY, Wen CP, Wheeler DC, Yatsuya H, Yamagata K, Yang JW, Young A, Zhang H, Zhang L, Levey AS, Gansevoort RT. Writing Group for the CKD Prognosis Consortium, et al. Among authors: naimark d. JAMA. 2023 Oct 3;330(13):1266-1277. doi: 10.1001/jama.2023.17002. JAMA. 2023. PMID: 37787795 Free PMC article.
Prescribing patterns and factors associated with sodium-glucose cotransporter-2 inhibitor prescribing in patients with diabetes mellitus and atherosclerotic cardiovascular disease.
Ozaki AF, Ko DT, Chong A, Fang J, Atzema CL, Austin PC, Stukel TA, Tu K, Udell JA, Naimark D, Booth GL, Jackevicius CA. Ozaki AF, et al. Among authors: naimark d. CMAJ Open. 2023 Jun 13;11(3):E494-E503. doi: 10.9778/cmajo.20220039. Print 2023 May-Jun. CMAJ Open. 2023. PMID: 37311594 Free PMC article.
169 results